Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR) November 17, 2026
AGC Biologics Mengalu-alukan Pelbagai Projek Terapi Sel ke Fasiliti Baharu di Yokohama November 17, 2026
Evolution Metals & Technologies Corp. Reports Third Quarter 2026 Financial Results and Provides Corporate Update November 16, 2026
Caribbean AI Takes Center Stage on Wall Street as Future Caribbean Names Its Top Startups November 16, 2026